1. Abaza, A., Bodinier, C., Aziza, C.I., Garnier, J.C.: Etude clinique d'un nouvel antiarythmique. Coer Méd. intern.,11, 757 (1972)
2. Abendroth, R.R., Hübner, H., Stephan, K., Meesmann, W.: Prophylaxe der Herzrhythmusstörungen beim akuten experimentellen Myokardinfarkt durch das β-Sympathikolytikum ICI 66082 (Atenolol). Verh. Dtsch. Ges. f. Inn. Med.82, 1102 (1976)
3. Abrams, W.B., Davies, O.R.: The antiarrhythmic mechanisms of beta-adrenergic blocking agents. In: Cardiac arrhythmias, 25. Hahnemann Symp. (Grune et Stratton) p. 517 edit. by New York: L.S. Dreifuss, W. Linkoff 1973
4. Achuff, S.C., Campbell, R.W.F., Pottage, A., Murray, A., Prescott, L., Julian, D.G.: Mexiletine in the prevention of ventricular dysrhythmus in acute myocardial infarction. Circulation 51–52 (suppl. II): 147 (1975)
5. Adgey, A.A.J., Goedes, J.S., Mulholland, H.C., Keegan, D.A.J., Pantridge, J.F.: Incidence, significance and management of early bradyarrhythmias complicating acute myocardial infarction. Lancet2, 1097 (1968)